Back
BioXcel Therapeutics Stock Predictions
Sponsored
Secure Your Family's Future in 15 Seconds With Gold-IRA
Take 15 Seconds to get the FREE Inflation Survival Plan and ensure your family's financial security.
Sell
32
BTAI
BioXcel Therapeutics
Last Price:
18.25
Seasonality Move:
46.06%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
20-cent Gold Stock Has Backing of Major Gold Producers
The time to get in is now BEFORE next drill results are released.BioXcel Therapeutics Stock Forecast
- Over the next 52 weeks, BioXcel Therapeutics has on average historically risen by 45.9% based on the past 4 years of stock performance.
- BioXcel Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is BioXcel Therapeutics Stock Undervalued?
The current BioXcel Therapeutics [BTAI] share price is $17.80. The Score for BTAI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - BTAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will BioXcel Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, BioXcel Therapeutics has on average historically risen by 45.9% based on the past 4 years of stock performance.
BioXcel Therapeutics Stock Rating
Sell
32
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics overpriced?
- BioXcel Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
BioXcel Therapeutics Stock Price History
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
bioxceltherapeutics.com
52-Week Data
52-Week High:
34.13
52-Week Low:
8.80
Prediction Charts
Market Cap:
516.37M
Price in USD:
17.80
Volume:
519.89K
Beta:
1.21
Technical Analysis
SMA50:
28.32
SMA100:
22.74
SMA200:
18.02
52-Wk Change:
-5.17%
Stock Predictions
-
Is BioXcel Therapeutics stock public?
Yes, BioXcel Therapeutics is a publicly traded company. -
What is the BioXcel Therapeutics stock quote today?
The BioXcel Therapeutics stock price is 17.80 USD today. -
How to buy BioXcel Therapeutics stock online?
You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 30.05 | 30.24 | 30.90 | 29.31 |
| Mar-6 | 30.44 | 30.14 | 30.53 | 29.41 |
| Mar-7 | 30.24 | 28.48 | 30.52 | 28.41 |
| Mar-8 | 28.44 | 28.36 | 29.10 | 27.93 |
| Mar-9 | 26.92 | 24.56 | 28.49 | 24.32 |
| Mar-10 | 22.89 | 20.66 | 23.10 | 20.26 |
| Mar-13 | 20.06 | 21.48 | 22.45 | 20.05 |
| Mar-14 | 21.57 | 20.33 | 22.53 | 20.02 |
| Mar-15 | 19.50 | 19.60 | 20.33 | 19.42 |
| Mar-16 | 19.20 | 19.44 | 20.02 | 19.06 |
| Mar-17 | 19.12 | 19.29 | 19.63 | 18.54 |
| Mar-20 | 19.33 | 18.86 | 19.54 | 17.66 |
| Mar-21 | 19.27 | 19.36 | 20.21 | 19.06 |
| Mar-22 | 19.25 | 17.80 | 19.25 | 17.80 |
BioXcel Therapeutics Earnings
BioXcel Therapeutics Earnings Report: Per Share BioXcel Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioXcel Therapeutics Forecast Revenue Growth
BioXcel Therapeutics Stock Analysis: Historical quarterly revenues per share for BioXcel Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.17 per share, and an increase next year of $1.92 per share.
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.